Dimensional Fund Advisors
ANRO icon

Dimensional Fund Advisors’s Alto Neuroscience ANRO Stock Holding History

Dimensional Fund Advisors’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$884K Buy
39,324
+8,148
+26% +$151K ﹤0.01% 2862
2025
Q4 		$555K Buy
+31,176
New +$393K ﹤0.01% 2958

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors's ANRO Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Alto Neuroscience (ANRO) stake by 26% in Q1 2026, buying an estimated $151K and bringing the position to 39,324 shares worth $884K. The position accounts for ﹤0.01% of the portfolio, ranked #2862.

Dimensional Fund Advisors first reported a position in ANRO in Q4 2025 and has held it in 2 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Dimensional Fund Advisors held 39,324 shares of Alto Neuroscience worth $884K as of Q1 2026.
  • Dimensional Fund Advisors bought 8,148 Alto Neuroscience shares in Q1 2026, an estimated $151K.
  • Alto Neuroscience made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2862 holding.
  • Dimensional Fund Advisors first reported a position in Alto Neuroscience in Q4 2025 and has held it in 2 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.